2nd Quarter - Report

HARM REDUCTION COALITION for HARM REDUCTION COALITION

Period 2nd Quarter 2012 Filed Oct 23, 2012 Signed by Whitney Englander, Government Relations Manager

Official filing
Firm
HARM REDUCTION COALITION
Client
HARM REDUCTION COALITION
Income
—
Expenses
$20,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Aug 7, 2012 $20,000 Replaced
2nd Quarter - Report (this page) Oct 23, 2012 $20,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Prescription drug abuse and overdose prevention. Access to naloxone. Hepatitis C research, testing and treatment

LobbyistCovered position, as disclosed
WHITNEY ENGLANDER —

Contacted: Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; Office of Natl Drug Control Policy (NDCP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.